SalfordOnline
Your local community website
New Discovery to Pave Way for New Class of AIDS Drug
A team of researchers at the renowned Scripps Research Institute has discovered two new compounds that prove the existence of new binding sites on HIV protease. According to the World Health Organization, about 33 million people currently live with HIV infections. Several drugs used to treat AIDS inhibit this HIV protease target, but drug-resistant mutants that impede the effectiveness of these drugs keep appearing and getting worse. Utilizing computing power from 1.5 million devices networked through IBM's World Community Grid, the new sites on the HIV protease are being used as docking targets for virtual screening experiments, in order to guide the development of these chemical compounds into a new class of potent HIV inhibitors. IBM World Community Grid Announcement with Scripps Research Institute Shotlist: Exterior Scripps Research Institute Animation of AIDS Virus Dr. Olson at computer, Scripps Worker in Scripps lab Models of HIV virus HIV virus on screen CU HIV model Worker in Scripps lab HIV/AIDS graphic Int. Dr. Olson, Scripps Person at computer WCG graphic WCG web site People at computer Dr. Jasinski int., IBM Animation of HIV/AIDS virus Person at computer Animation of HIV/AIDS virus Worker in lab US Capital Lab shots WCG web site Person at computer Fight AIDS@Home graphic Dr. Olson int. WCG graphic Due to problems with spam only SalfordOnline members can now leave comments. Becoming a member of SalfordOnline only takes a minute, just hit the red Join Us button at the top right hand side of the page to create your Personal account. Got a news story? Need help with publicity for an event in Salford? Send it to newsdesk@salfordonline.com or call the SalfordOnline newsdesk on 0161 789 5377. |
